Immix Biopharma, Inc. IMMX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $482.51M.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s market capitalization?
- Immix Biopharma, Inc. (IMMX) reported market capitalization of $482.51M in Q1 2026.
- How has Immix Biopharma, Inc.'s market capitalization changed year-over-year?
- Immix Biopharma, Inc.'s market capitalization increased by 936.0% year-over-year, from $46.57M to $482.51M.
- What is the long-term trend for Immix Biopharma, Inc.'s market capitalization?
- Over 4 years (2021 to 2025), Immix Biopharma, Inc.'s market capitalization has grown at a 53.8% compound annual growth rate (CAGR), from $49.24M to $275.6M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.